GAC63, a GRIP1-dependent nuclear receptor coactivator.

Area of Science:

• Molecular Biology
• Gene Regulation
• Endocrinology

Background:

• Nuclear receptors (NRs) control gene transcription via coactivator complexes.
• p160 coactivators and their partners (e.g., p300, CARM1) are crucial for transcriptional activation.
• Mechanisms of NR-mediated gene regulation are complex and involve protein modifications.

Purpose of the Study:

• To identify and characterize novel coactivators involved in NR-mediated transcription.
• To elucidate the role of GAC63 in the p160 coactivator signaling pathway.
• To investigate the functional interaction of GAC63 with NRs and other coactivators.

Main Methods:

• Co-immunoprecipitation assays to identify GAC63 binding partners.
• Transient transfection assays to assess GAC63's effect on NR transcriptional activity.
• Small interfering RNA (siRNA) to reduce endogenous GAC63 levels.
• Chromatin immunoprecipitation (ChIP) to detect GAC63 recruitment to gene promoters.

Main Results:

• GAC63 was identified as a novel coactivator that binds to p160 coactivators and NR ligand-binding domains.
• GAC63 enhances NR-mediated transcription in a hormone-dependent and GRIP1-dependent manner.
• GAC63 synergistically enhances estrogen receptor function with coactivators like GRIP1 and CARM1.
• Endogenous GAC63 is recruited to the estrogen-responsive pS2 promoter upon hormone stimulation.
• siRNA-mediated knockdown of GAC63 impairs hormone-activated estrogen receptor-mediated transcription.

Conclusions:

• GAC63 is a novel, physiologically relevant coactivator in the NR signaling pathway.
• GAC63 plays a critical role in mediating transcriptional activation by NRs, particularly the estrogen receptor.
• GAC63 functions within the p160 coactivator complex to regulate gene expression.